GGrantIndex
Sort

85,873 grants matching alzheimers

CLINICAL CORE

$804,938
Richard J. Caselli · Banner Sun Health Research Institute · P30 · FY2009 · AG

Harmonization of Multi-Site Neuroimaging Data from Complex Study Designs

$804,915
Russell Takeshi Shinohara · University Of Pennsylvania · R01 · FY2025 · MH

Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP

$804,861
Thomas C Neylan · University Of California, San Francisco · R01 · FY2022 · AG

Neural Correlates of Cognitive-Motor Interactions in ADRD Gait

$804,795
Rachael D Seidler · University Of Florida · R01 · FY2024 · AG

Sleep Aging and Risk for Alzheimer's disease-Resubmission-1

$804,788
Ricardo S Osorio · New York University School Of Medicine · R01 · FY2022 · AG

EVALUATING EFFECTS IN THE RELATIONSHIP BETWEEN TRAUMATIC BRAIN INJURY AND ALZHEIMERS DISEASE EPIDEMIOLOGICAL DETERMINANTS

$804,775
Duke University · · FY2020 · Defense Health Agency

Immune Cells in Alzheimer’s Disease and Related Dementias in the Jackson Heart Study

$804,770
Laura M Raffield · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AG

Light, metabolic syndrome and Alzheimer’s disease: a non-pharmacological approach

$804,753
Mariana Gross Figueiro · Rensselaer Polytechnic Institute · R01 · FY2019 · AG

Defining the pathogenic relationship of TDP-43 inclusions and cytoplasmic double stranded RNA in AD and FTD

$804,740
Mark W Albers · Harvard Medical School · R01 · FY2025 · AG

Dominantly Inherited Alzheimer Network: Project 3

$804,703
Anne Fagan Niven · Washington University · U19 · FY2021 · AG

Optimization and evaluation of novel benzimidazoles for the treatment of Alzheimer's Disease

$804,677
Kevin Hodgetts · Brigham And Women'S Hospital · U01 · FY2023 · AG

COVID-19-related blood-brain barrier and microstructural brain injury; Sex differences and synergy with Alzheimer's disease risk

$804,670
Emilie T. Reas · University Of California, San Diego · R01 · FY2023 · AG

Developing Novel Soluble Epoxide Hydrolase Inhibitors for the Treatment of Alzheimer's Disease

$804,669
Jin Wang · Baylor College Of Medicine · U01 · FY2024 · AG

Autoimmune features of neurodegenerative disorders

$804,632
David Sulzer · Columbia University Health Sciences · R01 · FY2021 · NS

MEASURING GLIAL METABOLISM IN REPETITIVE BRAIN TRAUMA AND ALZHEIMER'S DISEASE

$804,585
Brigham & Womens Hospital Inc · · FY2015 · Department of the Army

Neuropathology Core

$804,573
William W Seeley · Mayo Clinic Rochester · U19 · FY2024 · AG

A Multilevel Investigation of Migration and Dementia Risk Among Mexican Americans

$804,568
Adina Zeki Al Hazzouri · Columbia University Health Sciences · R01 · FY2025 · AG

Role of Peripheral Immune Cells in Cognitive Aging: The Framingham Offspring Study

$804,541
Joanne M Murabito · Boston University Medical Campus · R01 · FY2020 · AG

Ultra High Resolution Brain PET Scanner for in-vivo Autoradiography Imaging

$804,536
Georges El Fakhri · Massachusetts General Hospital · U01 · FY2020 · EB

Personalized genetic profiles of risk and resilience in Alzheimer's and vascular diseases

$804,525
Alexander M Kulminski · Duke University · R01 · FY2020 · AG

First-in-Human evaluation of an astrocytic glutamate transporter (EAAT2) PET tracer in healthy and Alzheimer's diseased brain

$804,521
David M Wilson · University Of California, San Francisco · R01 · FY2025 · AG

Targeting Nell2 and GABAergic Dysfunction to Mitigate APOE4-Driven Pathogenesis in Alzheimer's Disease

$804,450
Misha Yuri Zilberter · J. David Gladstone Institutes · R01 · FY2025 · AG

Administrative Core

$804,446
Erik D Roberson · University Of Alabama At Birmingham · P30 · FY2024 · AG

Brain Effects of Lifetime Racial/Ethnic Discrimination on the LC-NE Function and the Risk for Alzheimer's Disease

$804,442
Yu-Shin Ding · New York University School Of Medicine · R01 · FY2024 · AG

Adult Changes in Thought (ACT) Research Program Core C: Life Course Core

$804,341
Sarah Elizabeth Tom · Kaiser Foundation Research Institute · U19 · FY2024 · AG